Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated ...

AS GLP-1 AGONISTS soar in popularity—about 12 percent of the U.S. population has tried one, most often Ozempic or Wegovy ...

Jelly Roll is giving details on his weight loss journey. The 40-year-old singer appeared on the December 16 episode his of ...

Part of the joy of the season may be gone — or feel different — for people who are taking popular weight-loss drugs and can't ...

Jelly Roll looked back on his relationship with food before his recent dramatic weight loss. He says he dropped the weight ...

Notable decrease seen in South, which had highest prescription rates for Ozempic, Wegovy and other weight loss meds ...

Health Canada has approved Omlyclo, the first omalizumab biosimilar in Canada, for the treatment of chronic idiopathic ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

The Danish Medicines Agency had been watching reports of a rare eye disease in patients who took Novo’s GLP-1 drug but until ...

Novo Nordisk (NVO) is making headlines with its inventive investment of $1.2 billion aimed at building a new production ...

Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance ...